Date | Time | Source | Announcement |
---|---|---|---|
06 Nov 2024 | 07:00 AM | Q3 Trading Statement | |
05 Nov 2024 | 01:31 PM | Holding(s) in Company | |
01 Nov 2024 | 03:59 PM | Total Voting Rights | |
01 Oct 2024 | 01:19 PM | Total Voting Rights | |
24 Sep 2024 | 12:25 PM | Director/PDMR Shareholding | |
02 Sep 2024 | 01:44 PM | Total Voting Rights | |
08 Aug 2024 | 07:00 AM | Half Year Results | |
01 Aug 2024 | 02:32 PM | Total Voting Rights | |
23 Jul 2024 | 10:28 AM | Directorate Change | |
01 Jul 2024 | 01:10 PM | Total Voting Rights | |
19 Jun 2024 | 02:48 PM | Director/PDMR Shareholding | |
03 Jun 2024 | 12:33 PM | Block listing Interim Review | |
03 Jun 2024 | 11:08 AM | Total Voting Rights | |
23 May 2024 | 07:00 AM | Confirmation of CFO start date | |
01 May 2024 | 01:11 PM | Total Voting Rights | |
30 Apr 2024 | 02:03 PM | Directorate Change | |
25 Apr 2024 | 02:09 PM | Result of AGM | |
25 Apr 2024 | 07:00 AM | Q1 Trading Statement | |
02 Apr 2024 | 01:49 PM | Total Voting Rights | |
28 Mar 2024 | 12:53 PM | Director/PDMR Shareholding | |
25 Mar 2024 | 04:47 PM | Director/PDMR Shareholding | |
25 Mar 2024 | 02:07 PM | Annual Report 2023 and Notice of AGM 2024 | |
12 Mar 2024 | 01:38 PM | Director/PDMR Shareholding | |
12 Mar 2024 | 07:00 AM | Full Year Results | |
11 Jan 2024 | 06:00 PM | Dechra Pharmaceuticals | |
10 Jan 2024 | 07:00 AM | Trading Statement | |
01 Dec 2023 | 04:48 PM | Block listing Interim Review | |
01 Dec 2023 | 04:45 PM | Total Voting Rights | |
17 Nov 2023 | 10:25 AM | Holding(s) in Company | |
08 Nov 2023 | 07:00 AM | Appointment of Chief Financial Officer | |
07 Nov 2023 | 07:00 AM | Q3 Trading Statement | |
03 Nov 2023 | 01:15 PM | Holding(s) in Company | |
01 Sep 2023 | 01:15 PM | Total Voting Rights | |
10 Aug 2023 | 07:04 AM | Half Year Results | |
27 Jul 2023 | 10:13 AM | Directorate Change | |
10 Jul 2023 | 09:27 AM | Director Declaration | |
03 Jul 2023 | 02:46 PM | Total Voting Rights | |
01 Jun 2023 | 04:38 PM | TR-1: Notification of major holdings | |
01 Jun 2023 | 01:07 PM | Block listing Interim Review | |
01 Jun 2023 | 11:06 AM | Total Voting Rights | |
03 May 2023 | 05:00 PM | Holding(s) in Company | |
03 May 2023 | 04:12 PM | Director/PDMR Shareholding | |
02 May 2023 | 11:13 AM | Total Voting Rights | |
26 Apr 2023 | 04:32 PM | Result of AGM | |
26 Apr 2023 | 07:00 AM | Q1 Trading Statement | |
03 Apr 2023 | 04:01 PM | Director/PDMR Shareholding | |
03 Apr 2023 | 03:05 PM | Total Voting Rights | |
27 Mar 2023 | 03:44 PM | Director/PDMR Shareholding | |
22 Mar 2023 | 03:00 PM | Annual Report 2022 and Notice of AGM 2023 | |
13 Mar 2023 | 01:57 PM | Directorate Change |
Persimmon plc is a British housebuilding company, headquartered in York, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Persimmon was founded by Duncan Davidson in 1972.The company is named after a horse which won the 1896 Derby and St. Leger for the Prince of Wales (the future Edward VII). After leaving George Wimpey, Davidson had formed Ryedale Homes in 1965, selling it to Comben Homes in 1972 for £600,000. Davidson restarted development again in the Yorkshire area; Persimmon began to expand regionally with the formation of an Anglian division in 1976 followed by operations in the Midlands and the south-west. In 1984, Persimmon bought Tony Fawcett’s Sketchmead company; Fawcett had been a director of Ryedale and he became deputy managing director at Persimmon. The enlarged company was floated on the London Stock Exchange in 1985, by which time the Company was building around 1,000 houses a year.
Persimmon share price launched at 144p in 1988.